ArticleJournal of translational medicine2026
Symptom-based clusters in people with post-COVID-19 condition (PCC).
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdentifying symptom clusters in post-COVID-19 condition (PCC) is a necessary step toward for developing more targeted therapeutic interventions for this heterogeneous condition. Therefore, the aim of this study was to identify symptom clusters based on 14 specific PCC symptoms, accounting for both symptom presence and impairment. The identified clusters were then compared with respect to sociodemographic, clinical, and psychological factors.
methodsA clinical sample of individuals with a PCC diagnosis lasting at least one year was included (final n = 1673). A two-step cluster analysis was performed to identify symptom clusters. Subsequent comparisons between clusters were performed using Mann-Whitney U tests for continuous variables and chi-square tests for categorical variables.
resultsA total of four clusters were identified: two symptom burden clusters (Systemic (high burden) and Few Symptoms (low burden)) and two symptom-specific clusters (Neurocognitive and Pain). Participants in the Systemic (high burden) cluster exhibited the highest levels of psychological distress, reported the most severe fatigue, and were most frequently unemployed.
conclusionIn PCC, different symptom clusters can be identified that differ in terms of sociodemographic, clinical, and psychological factors. Future research using biomarker, imaging, and longitudinal designs is needed to determine whether these symptom-based clusters correspond to distinct biological subgroups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.